Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVED: Induction therapy with Methotrexate and Prednisone in Rheumatoid Or Very Early Arthritic Disease
2006-006186-16Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methotrexate and prednisone in rheumatoid arthritis (RA) and undifferentiated arthritis (UA) (3 arms), sponsored by Leiden University Medical Center. Primary endpoints: Clinical remission at 4 months and Clinical remission at 1 year in randomized arms. Started Jul 2007; status: active.
02
Drugs
methotrexateprednisone
03
Conditions
rheumatoid arthritis (RA)undifferentiated arthritis (UA)
Beyond the preview
Go deeper on 2006-006186-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006186-16.